Evolus, Inc. (EOLS)
7.79
-0.78
(-9.10%)
USD |
NASDAQ |
Sep 10, 13:09
Evolus Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2025 | 138.57 |
| March 27, 2025 | 140.76 |
| March 26, 2025 | 142.94 |
| March 25, 2025 | 142.94 |
| March 24, 2025 | 149.50 |
| March 21, 2025 | 149.84 |
| March 20, 2025 | 152.37 |
| March 19, 2025 | 154.90 |
| March 18, 2025 | 152.72 |
| March 17, 2025 | 156.28 |
| March 14, 2025 | 151.80 |
| March 13, 2025 | 149.04 |
| March 12, 2025 | 154.32 |
| March 11, 2025 | 146.16 |
| March 10, 2025 | 145.82 |
| March 07, 2025 | 156.16 |
| March 06, 2025 | 155.24 |
| March 05, 2025 | 162.95 |
| March 04, 2025 | 165.02 |
| March 03, 2025 | 164.90 |
| February 28, 2025 | 167.78 |
| February 27, 2025 | 161.68 |
| February 26, 2025 | 164.67 |
| February 25, 2025 | 160.53 |
| February 24, 2025 | 162.26 |
| Date | Value |
|---|---|
| February 21, 2025 | 160.88 |
| February 20, 2025 | 168.12 |
| February 19, 2025 | 171.11 |
| February 18, 2025 | 170.08 |
| February 14, 2025 | 169.50 |
| February 13, 2025 | 172.95 |
| February 12, 2025 | 163.98 |
| February 11, 2025 | 158.35 |
| February 10, 2025 | 150.76 |
| February 07, 2025 | 150.76 |
| February 06, 2025 | 154.21 |
| February 05, 2025 | 156.05 |
| February 04, 2025 | 149.50 |
| February 03, 2025 | 149.27 |
| January 31, 2025 | 160.65 |
| January 30, 2025 | 163.41 |
| January 29, 2025 | 167.43 |
| January 28, 2025 | 163.64 |
| January 27, 2025 | 169.73 |
| January 24, 2025 | 163.64 |
| January 23, 2025 | 161.22 |
| January 22, 2025 | 162.49 |
| January 21, 2025 | 155.02 |
| January 17, 2025 | 120.86 |
| January 16, 2025 | 122.01 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.710 |
| Corcept Therapeutics, Inc. | 17.65 |
| Veru, Inc. | 1.508 |
| Johnson & Johnson | 7.553 |
| Eli Lilly & Co. | 31.31 |
Price to Book Value Related Metrics
| PS Ratio | 1.607 |
| Price | 7.79 |
| Earnings Yield | -6.77% |
| Market Cap | 514.25M |